Skip to content
Back to PCVX

Vaxcyte, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
61
Purchases
0
Sales
61
Purchase value
$0.00
Sale value
$13.84M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Harpreet S. DhaliwalChief Technical Ops Officer
4Rule 10b5-1 plan disclosed
Filed Nov 13, 2026Period of report Nov 11, 20260001886794-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF1F27,135$67.33$480.40K77,950Direct
SaleNov 11, 2026
Common StockF1F39,345$68.156$636.92K68,605Direct
SaleNov 11, 2026
Common StockF1F4F5520$68.819$35.79K68,085Direct
Filing footnotes · 6
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $66.76 to $67.755. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $67.76 to $68.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $68.76 to $68.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. F5No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated October 6, 2026 were sold by the Reporting Person.
  6. F6Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Elvia CowanSVP, Finance & CAO
4Rule 10b5-1 plan disclosed
Filed Nov 4, 2026Period of report Nov 2, 20260001960048-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 2, 2026
Common StockF1F22,414$60.765$146.69K28,446Direct
SaleNov 2, 2026
Common StockF1F3586$61.547$36.07K27,860Direct
Filing footnotes · 4
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $60.345 to $61.325. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $61.425 to $61.92. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilEVP, Chief Scientific Ofc, COO
4Rule 10b5-1 plan disclosed
Filed Nov 4, 2026Period of report Nov 2, 20260001813798-26-000025
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 2, 2026
Common StockF1F21,907$60.779$115.91K145,778Direct
SaleNov 2, 2026
Common StockF1F3343$61.57$21.12K145,435Direct
Filing footnotes · 4
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $60.385 to $61.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $61.40 to $61.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
  4. F4Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Elvia CowanSVP, Finance & CAO
4Rule 10b5-1 plan disclosed
Filed Oct 7, 2026Period of report Oct 5, 20260001960048-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 5, 2026
Common StockF119,000$86.74$1.65M27,860Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.
  2. F2Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilEVP, Chief Scientific Ofc, COO
4Rule 10b5-1 plan disclosed
Filed Oct 7, 2026Period of report Oct 5, 20260001813798-26-000023
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 5, 2026
Common StockF118,000$86.74$1.56M145,435Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilEVP, Chief Scientific Ofc, COO
4Rule 10b5-1 plan disclosed
Filed Oct 2, 2026Period of report Oct 1, 20260001813798-26-000021
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common StockF1F22,155$56.654$122.09K145,530Direct
SaleOct 1, 2026
Common StockF1F395$57.094$5.42K145,435Direct
Filing footnotes · 4
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $56.065 to $56.955. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $57.09 to $57.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilEVP, Chief Scientific Ofc, COO
4
Filed Sep 9, 2026Period of report Sep 4, 20260001813798-26-000019
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 9, 2026
Common StockF1F41,334$59.521$79.40K145,435Direct
SaleSep 4, 2026
Common StockF1F21,381$61.16$84.46K152,228Direct
Filing footnotes · 4
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
  4. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4
Filed Sep 2, 2026Period of report Aug 31, 20260001813798-26-000017
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Common StockF2F31,537$60.886$93.58K156,981Direct
SaleSep 1, 2026
Common StockF2F4713$61.481$43.84K156,268Direct
SaleSep 1, 2026
Common StockF2F5924$60.955$56.32K155,344Direct
SaleSep 1, 2026
Common StockF2F6303$61.424$18.61K155,041Direct
Filing footnotes · 7
  1. F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. F5The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. F6The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. F7Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Harpreet S. DhaliwalChief Technical Ops Officer
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 5, 20260001886794-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 5, 2026
Common StockF2F317,000$55.004$935.07K76,756Direct
Filing footnotes · 4
  1. F1Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001813798-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF2F3861$53.502$46.07K158,930Direct
SaleAug 3, 2026
Common StockF2F41,389$54.089$75.13K157,541Direct
Filing footnotes · 5
  1. F1Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $52.915 to $53.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $53.935 to $54.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. F5Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Andrew GuggenhimePRESIDENT AND CFO
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001230724-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF2F36,956$53.761$373.96K108,220Direct
SaleAug 3, 2026
Common StockF2F43,044$54.178$164.92K105,176Direct
Filing footnotes · 6
  1. F1Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
  2. F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $53.06 to $54.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $54.07 to $54.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. F5Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.
  6. F6Option is fully vested and exercisable.
Open on SEC EDGAR
Grant PickeringDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Jul 28, 2026Period of report Jul 27, 20260001258693-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 27, 2026
Common StockF2F311,783$55.515$654.13K457,662Direct
SaleJul 27, 2026
Common StockF2F44,415$55.931$246.94K453,247Direct
SaleJul 27, 2026
Common StockF2F5F6756$55.516$41.97K133,459IndirectBy Children's Trust
SaleJul 27, 2026
Common StockF2F7F6244$55.964$13.66K133,215IndirectBy Children's Trust
SaleJul 27, 2026
Common StockF2F5F8622$55.54$34.55K133,593IndirectBy Children's Trust
SaleJul 27, 2026
Common StockF2F9F8378$55.914$21.14K133,215IndirectBy Children's Trust
Filing footnotes · 10
  1. F1Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
  2. F10Option is fully vested and exercisable.
  3. F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026.
  4. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $55.77 to $56.13. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. F5The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. F6Shares are held directly by a trust for the benefit of the Reporting Person's son.
  8. F7The price reported is a weighted-average price. The shares were sold at prices ranging from $55.81 to $56.18. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  9. F8Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
  10. F9The price reported is a weighted-average price. The shares were sold at prices ranging from $55.82 to $56.085. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Andrew GuggenhimePRESIDENT AND CFO
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 6, 20260001230724-26-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF1F27,913$57.157$452.28K106,482Direct
SaleJul 6, 2026
Common StockF1F32,087$57.764$120.55K104,395Direct
Filing footnotes · 5
  1. F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $56.595 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $57.61 to $58.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.
  5. F5Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001813798-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F21,788$56.03$100.18K157,222Direct
SaleJul 1, 2026
Common StockF1F3456$57.473$26.21K156,766Direct
SaleJul 1, 2026
Common StockF16$57.82$346.92156,760Direct
Filing footnotes · 4
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $55.60 to $56.595. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $56.695 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4Stock Option is fully vested and exercisable.
Open on SEC EDGAR
Grant PickeringDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Jun 26, 2026Period of report Jun 26, 20260001258693-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 26, 2026
Common StockF1F26,683$54.275$362.72K468,020Direct
SaleJun 26, 2026
Common StockF1F39,137$55.265$504.96K458,883Direct
SaleJun 26, 2026
Common StockF1F46,417$56.121$360.13K452,466Direct
SaleJun 26, 2026
Common StockF1F5F6312$54.345$16.96K134,903IndirectBy Children's Trust
SaleJun 26, 2026
Common StockF1F7F6356$55.226$19.66K134,547IndirectBy Children's Trust
SaleJun 26, 2026
Common StockF1F8F6332$55.993$18.59K134,215IndirectBy Children's Trust
SaleJun 26, 2026
Common StockF1F9F10207$54.222$11.22K135,008IndirectBy Children's Trust
SaleJun 26, 2026
Common StockF1F11F10602$55.297$33.29K134,406IndirectBy Children's Trust
SaleJun 26, 2026
Common StockF1F12F10191$56.266$10.75K134,215IndirectBy Children's Trust
Filing footnotes · 12
  1. F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026.
  2. F10Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
  3. F11The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F12The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $53.755 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $54.755 to $55.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $55.815 to $56.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  8. F5The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  9. F6Shares are held directly by a trust for the benefit of the Reporting Person's son.
  10. F7The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.51. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  11. F8The price reported is a weighted-average price. The shares were sold at prices ranging from $55.88 to $56.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  12. F9The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Grant PickeringDirector · CHIEF EXECUTIVE OFFICER
4Rule 10b5-1 plan disclosed
Filed Jun 18, 2026Period of report Jun 18, 20260001258693-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 18, 2026
Common StockF1225$52.51$11.81K496,939Direct
SaleJun 18, 2026
Common StockF122,236$52.50$1.17M474,703Direct
SaleJun 18, 2026
Common StockF1F21,000$52.50$52.50K135,215IndirectBy Children's Trust
SaleJun 18, 2026
Common StockF1F31,000$52.50$52.50K135,215IndirectBy Children's Trust
Filing footnotes · 4
  1. F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026.
  2. F2Shares are held directly by a trust for the benefit of the Reporting Person's son.
  3. F3Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
  4. F4Option is fully vested and exercisable.
Open on SEC EDGAR
Andrew GuggenhimePRESIDENT AND CFO
4Rule 10b5-1 plan disclosed
Filed Jun 18, 2026Period of report Jun 18, 20260001230724-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 18, 2026
Common StockF110,000$53.00$530.00K104,395Direct
Filing footnotes · 3
  1. F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
  2. F2Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.
  3. F3Option is fully vested and exercisable.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260001813798-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F21,949$49.404$96.29K158,795Direct
SaleJun 1, 2026
Common StockF1F3301$50.257$15.13K158,494Direct
Filing footnotes · 3
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $49.03 to $49.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $50.205 to $51.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed May 1, 2026Period of report May 1, 20260001813798-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF1F22,250$56.831$127.87K160,744Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $56.425 to $57.26. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Elvia CowanSVP, Finance & CAO
4Rule 10b5-1 plan disclosed
Filed Apr 8, 2026Period of report Apr 7, 20260001960048-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 7, 2026
Common StockF13,000$60.00$180.00K28,975Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.
  2. F21/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed Apr 3, 2026Period of report Apr 1, 20260001813798-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF1F21,412$58.138$82.09K165,406Direct
SaleApr 1, 2026
Common StockF1F3F4838$58.932$49.39K162,994Direct
Filing footnotes · 4
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $57.695 to $58.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $58.74 to $59.215. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the "Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. On March 25 and 26, 2026, the Reporting Person transferred 962 and 612 shares, respectively, of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings.
Open on SEC EDGAR
Elvia CowanSVP, Finance & CAO
4Rule 10b5-1 plan disclosed
Filed Mar 18, 2026Period of report Mar 17, 20260001960048-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 17, 2026
Common StockF1F21,487$55.387$82.36K29,380Direct
SaleMar 17, 2026
Common StockF1F3405$56.263$22.79K28,975Direct
Filing footnotes · 3
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.
  2. F2The price reported is a weighted-average price. The shares were sold at prices ranging from $54.98 to $55.935. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Elvia CowanSVP, Finance & CAO
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001960048-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 11, 2026
Common StockF22,500$58.5927$146.48K30,867Direct
Filing footnotes · 3
  1. F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.
  3. F31/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
Open on SEC EDGAR
Jim WassilCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001813798-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common StockF2F32,427$58.316$141.53K171,786Direct
SaleMar 10, 2026
Common StockF2F44,968$59.16$293.91K166,818Direct
Filing footnotes · 4
  1. F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
  3. F3The price reported is a weighted-average price. The shares were sold at prices ranging from $57.725 to $58.715. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. F4The price reported is a weighted-average price. The shares were sold at prices ranging from $58.74 to $59.575. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
Harpreet S. DhaliwalChief Technical Ops Officer
4
Filed Jan 2, 2026Period of report Dec 31, 20250001886794-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 31, 2025
Common StockF1F29,743$46.689$454.89K23,928Direct
Filing footnotes · 2
  1. F1The price reported is a weighted-average price. The shares were sold at prices ranging from $46.42 to $47.155. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. F2Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.
Open on SEC EDGAR
Elvia CowanSVP, FINANCE
4
Filed Dec 29, 2025Period of report Dec 23, 20250001960048-25-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 23, 2025
Common StockF14,907$47.899$235.04K21,250Direct
SaleDec 23, 2025
Common Stock6,716$47.935$321.93K14,534Direct
Filing footnotes · 2
  1. F1Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.
  2. F2Reflects the bona-fide gift of the Issuer's common stock to a Charitable Donor Advised Fund.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.